Hybrid drug-screening strategy identifies potential SARS-CoV-2 cell-entry inhibitors targeting human transmembrane serine proteaseYufei Feng, Wenxin Liu, Xiaoning Cheng et al.|Structural Chemistry|2022Cited by 7